Last reviewed · How we verify
NCT07477236
MyVitalC: Sleep and Everyday Headache Management
NA trial testing MyVitalC (ESS60 in Extra Virgin Olive Oil) in Sleep in 100 participants. Currently enrolling.
24 January 2027
Quick facts
| Lead sponsor | Efforia, Inc |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 100 |
| Start date | 24 January 2026 |
| Primary completion | 24 January 2027 |
| Estimated completion | 24 January 2027 |
| Sites | 1 location across United States |
Drugs / interventions tested
- MyVitalC (ESS60 in Extra Virgin Olive Oil)
Conditions studied
Sponsor
Efforia, Inc — full company profile →
Who can join
Eligibility, any sex, with Sleep or Headaches. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Sleep disturbance and recurring headaches can negatively affect daily functioning, mood, and productivity. MyVitalC (ESS60 in extra virgin olive oil) is a commercially available dietary supplement that has generated anecdotal claims related to sleep quality and headache relief; however, human data remain limited. This real-world observational study is designed to help participants evaluate whether use of MyVitalC is associated with changes in sleep disturbance and headache frequency or severity in their own daily lives. Participants will complete a four-week baseline observation period without the intervention, followed by six weeks of daily MyVitalC use, with weekly self-reported assessments. Participants serve as their own control, allowing for within-person comparison of outcomes before and during product use.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07477236
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sleep
Currently open trials in the same condition.
- NCT07413185 — Relationship Between the Severity of Sleep Deprivation in the First 48 Hours Postpartum, Breastfeeding Motivation, and B · recruiting
- NCT07401212 — GUTLINK4KIDS Intervention · NA · recruiting
- NCT07497698 — Saffron Extract Supplementation and Sleep Quality in Middle-Aged Adults · NA · recruiting
- NCT07213908 — Comparing Two School-Based Sleep Health Interventions To Promote Sleep Quality in Youth · NA · recruiting
- NCT06670287 — The Use of Multiple Sensors to Track Sleep in Nightshift Workers · NA · recruiting
Other Efforia, Inc trials
Trials by the same sponsor.
- NCT07477223 — Beef Versus Whey Protein: The Gut Showdown Self-Experiment · NA · recruiting
- NCT07478497 — 30 Day Insulin Balance Metabolic Health Optimization Protocol · NA · recruiting
- NCT07282275 — How Does Continued Use of Green Light Therapy Impact Outcomes? · NA · recruiting
- NCT07256639 — Evaluating Heart & Soil's Whole Package on Men's Health · NA · recruiting
- NCT07298382 — See the Impact Beem's Blue Light Therapy Has on Your Skin Health! · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07477236 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Efforia, Inc
- Last refreshed: 17 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07477236.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing